As your project advances to pivotal clinical stages, we scale up and optimize processes to ensure the supply of large-volume, highly consistent plasmid materials for global multi-center Phase II/III trials. We focus on inter-batch quality stability and reproducibility, implementing stricter release standards to guarantee medication safety and supply continuity throughout long-term clinical studies, thereby providing solid data support for market approval.